acid hemolysis test
Erythrocytes from patients with PNH, due to their inherent defects, have increased sensitivity to complement and are easily destroyed by hemolysis in acidified
Knowledge Base
Laboratory Protocols & SOPs Library
3,200+ step-by-step lab protocols and SOPs for cell culture, staining, PCR, protein work and microbiology, with reagents, conditions and evaluation criteria.
3228 articles
Glucose-6-phosphate dehydrogenase fluorescence spot test
In the presence of glucose-6-phosphate (GbB) and NADP, glucose-6-phosphate dehydrogenase (G6PD) is able to use NADP to reduce to NADPH, which does not fluoresce
Plasma ichthyoglobin sulfate paracoagulation time test
Under the action of thrombin, fibrinogen releases peptide A and peptide B, and then transforms into fibrin monomer (FM) and fibrin degradation product (FDP) to
hemolytic test
This test uses the patient's erythrocytes to cause hemolysis to occur after incubation in their own serum (containing complement) at 37°C due to acid productio
cold hemolysis test
Paroxysmal cold hemoglobinuria (PCH) is a kind of autoimmune hemolytic syndrome patients produce a kind of cold-reactive antibody (D-L antibody), this antibody
Indirect method for the detection of anti-human globulin test
The purpose of the indirect test is to check for the presence of free incomplete antibodies in the serum. First, Rh(D)-positive O-type (or the same type as the
Aplastic anemia analytical test
Retrovirus is an acquired myelopoietic dysfunction disease, the patient's bone marrow hematopoietic tissue is reduced, the red bone marrow is replaced by adipos
Analysis of bone marrow picture of acute lymphatic leukemia and experimental characterization of each subtype
l. Erythrocyte and hemoglobin depression is less severe than in acute granulomas, and juvenile erythrocytes are rare. 2. The white blood cell count is elevated
Primitive granulocytic leukemia undifferentiated type experiment
Acute primitive granulocytic leukemia (AML) is the most common type in adults, accounting for about 30.80% of acute leukemias, with an average of about 50%, and